*Non-invasive phenotyping of molecular brain tumour profiles using novel advanced MR imaging and analysis'

• Conditions: Brain tumour; Glioma; 10027655

• Registration Number: NL-OMON47240
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 300

Inclusion Criteria

- Individuals of 18 years or older
- Referred for surgery (resection or biopsy) of a primary brain tumour
- Written informed consent

Exclusion Criteria

- Contra-indication for MRI (implanted metal parts, e.g. stents, vascular clips, pacemakers)
- Inability to give consent

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Diagnostic accuracy (true / false positive / negative) in identification of<br /><br>Class 3 patients using structural and physiological MRI.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>na</p><br>